Synthetic triterpenoids, CDDO-Imidazolide and CDDO-Ethyl amide, induce chondrogenesis

N. Suh, S. Paul, H. J. Lee, T. Yoon, N. Shah, A. I. Son, A Hari Reddi, D. Medici, M. B. Sporn

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Novel methods for inducing chondrogenesis are critical for cartilage tissue engineering and regeneration. Here we show that the synthetic oleanane triterpenoids, CDDO-Imidazolide (CDDO-Im) and CDDO-Ethyl amide (CDDO-EA), at concentrations as low as 200 nM, induce chondrogenesis in organ cultures of newborn mouse calvaria. The cartilage phenotype was measured histologically with metachromatic toluidine blue staining for proteoglycans and by immunohistochemical staining for type II collagen. Furthermore, real-time polymerase chain reaction (PCR) analysis using mRNA from calvaria after 7-day treatment with CDDO-Im and CDDO-EA showed up-regulation of the chondrocyte markers SOX9 and type II collagen (alpha1). In addition, TGF-β; BMPs 2 and 4; Smads 3, 4, 6, and 7; and TIMPs-1 and -2 were increased. In contrast, MMP-9 was strongly down-regulated. Treatment of human bone marrow-derived mesenchymal stem cells with CDDO-Im and CDDO-EA (100 nM) induced expression of SOX9, collagen IIα1, and aggrecan, as well as BMP-2 and phospho-Smad5, confirming that the above triterpenoids induce chondrogenic differentiation. This is the first report of the use of these drugs for induction of chondrogenesis.

Original languageEnglish (US)
Pages (from-to)446-450
Number of pages5
JournalOsteoarthritis and Cartilage
Volume20
Issue number5
DOIs
StatePublished - May 2012

Fingerprint

Chondrogenesis
Collagen Type II
Amides
Collagen
Cartilage
Skull
Staining and Labeling
Aggrecans
Tissue Inhibitor of Metalloproteinase-2
Tolonium Chloride
Tissue regeneration
Tissue Inhibitor of Metalloproteinase-1
Organ Culture Techniques
Polymerase chain reaction
Proteoglycans
Tissue Engineering
Chondrocytes
Stem cells
Matrix Metalloproteinases
Mesenchymal Stromal Cells

Keywords

  • Calvarial organ cultures
  • Chondrogenesis
  • Stem cells
  • Synthetic oleanane triterpenoids
  • Triterpenoids

ASJC Scopus subject areas

  • Biomedical Engineering
  • Orthopedics and Sports Medicine
  • Rheumatology

Cite this

Suh, N., Paul, S., Lee, H. J., Yoon, T., Shah, N., Son, A. I., ... Sporn, M. B. (2012). Synthetic triterpenoids, CDDO-Imidazolide and CDDO-Ethyl amide, induce chondrogenesis. Osteoarthritis and Cartilage, 20(5), 446-450. https://doi.org/10.1016/j.joca.2012.01.018

Synthetic triterpenoids, CDDO-Imidazolide and CDDO-Ethyl amide, induce chondrogenesis. / Suh, N.; Paul, S.; Lee, H. J.; Yoon, T.; Shah, N.; Son, A. I.; Reddi, A Hari; Medici, D.; Sporn, M. B.

In: Osteoarthritis and Cartilage, Vol. 20, No. 5, 05.2012, p. 446-450.

Research output: Contribution to journalArticle

Suh, N, Paul, S, Lee, HJ, Yoon, T, Shah, N, Son, AI, Reddi, AH, Medici, D & Sporn, MB 2012, 'Synthetic triterpenoids, CDDO-Imidazolide and CDDO-Ethyl amide, induce chondrogenesis', Osteoarthritis and Cartilage, vol. 20, no. 5, pp. 446-450. https://doi.org/10.1016/j.joca.2012.01.018
Suh, N. ; Paul, S. ; Lee, H. J. ; Yoon, T. ; Shah, N. ; Son, A. I. ; Reddi, A Hari ; Medici, D. ; Sporn, M. B. / Synthetic triterpenoids, CDDO-Imidazolide and CDDO-Ethyl amide, induce chondrogenesis. In: Osteoarthritis and Cartilage. 2012 ; Vol. 20, No. 5. pp. 446-450.
@article{7d2e57d63a624fcd88822bef3a0e7503,
title = "Synthetic triterpenoids, CDDO-Imidazolide and CDDO-Ethyl amide, induce chondrogenesis",
abstract = "Novel methods for inducing chondrogenesis are critical for cartilage tissue engineering and regeneration. Here we show that the synthetic oleanane triterpenoids, CDDO-Imidazolide (CDDO-Im) and CDDO-Ethyl amide (CDDO-EA), at concentrations as low as 200 nM, induce chondrogenesis in organ cultures of newborn mouse calvaria. The cartilage phenotype was measured histologically with metachromatic toluidine blue staining for proteoglycans and by immunohistochemical staining for type II collagen. Furthermore, real-time polymerase chain reaction (PCR) analysis using mRNA from calvaria after 7-day treatment with CDDO-Im and CDDO-EA showed up-regulation of the chondrocyte markers SOX9 and type II collagen (alpha1). In addition, TGF-β; BMPs 2 and 4; Smads 3, 4, 6, and 7; and TIMPs-1 and -2 were increased. In contrast, MMP-9 was strongly down-regulated. Treatment of human bone marrow-derived mesenchymal stem cells with CDDO-Im and CDDO-EA (100 nM) induced expression of SOX9, collagen IIα1, and aggrecan, as well as BMP-2 and phospho-Smad5, confirming that the above triterpenoids induce chondrogenic differentiation. This is the first report of the use of these drugs for induction of chondrogenesis.",
keywords = "Calvarial organ cultures, Chondrogenesis, Stem cells, Synthetic oleanane triterpenoids, Triterpenoids",
author = "N. Suh and S. Paul and Lee, {H. J.} and T. Yoon and N. Shah and Son, {A. I.} and Reddi, {A Hari} and D. Medici and Sporn, {M. B.}",
year = "2012",
month = "5",
doi = "10.1016/j.joca.2012.01.018",
language = "English (US)",
volume = "20",
pages = "446--450",
journal = "Osteoarthritis and Cartilage",
issn = "1063-4584",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Synthetic triterpenoids, CDDO-Imidazolide and CDDO-Ethyl amide, induce chondrogenesis

AU - Suh, N.

AU - Paul, S.

AU - Lee, H. J.

AU - Yoon, T.

AU - Shah, N.

AU - Son, A. I.

AU - Reddi, A Hari

AU - Medici, D.

AU - Sporn, M. B.

PY - 2012/5

Y1 - 2012/5

N2 - Novel methods for inducing chondrogenesis are critical for cartilage tissue engineering and regeneration. Here we show that the synthetic oleanane triterpenoids, CDDO-Imidazolide (CDDO-Im) and CDDO-Ethyl amide (CDDO-EA), at concentrations as low as 200 nM, induce chondrogenesis in organ cultures of newborn mouse calvaria. The cartilage phenotype was measured histologically with metachromatic toluidine blue staining for proteoglycans and by immunohistochemical staining for type II collagen. Furthermore, real-time polymerase chain reaction (PCR) analysis using mRNA from calvaria after 7-day treatment with CDDO-Im and CDDO-EA showed up-regulation of the chondrocyte markers SOX9 and type II collagen (alpha1). In addition, TGF-β; BMPs 2 and 4; Smads 3, 4, 6, and 7; and TIMPs-1 and -2 were increased. In contrast, MMP-9 was strongly down-regulated. Treatment of human bone marrow-derived mesenchymal stem cells with CDDO-Im and CDDO-EA (100 nM) induced expression of SOX9, collagen IIα1, and aggrecan, as well as BMP-2 and phospho-Smad5, confirming that the above triterpenoids induce chondrogenic differentiation. This is the first report of the use of these drugs for induction of chondrogenesis.

AB - Novel methods for inducing chondrogenesis are critical for cartilage tissue engineering and regeneration. Here we show that the synthetic oleanane triterpenoids, CDDO-Imidazolide (CDDO-Im) and CDDO-Ethyl amide (CDDO-EA), at concentrations as low as 200 nM, induce chondrogenesis in organ cultures of newborn mouse calvaria. The cartilage phenotype was measured histologically with metachromatic toluidine blue staining for proteoglycans and by immunohistochemical staining for type II collagen. Furthermore, real-time polymerase chain reaction (PCR) analysis using mRNA from calvaria after 7-day treatment with CDDO-Im and CDDO-EA showed up-regulation of the chondrocyte markers SOX9 and type II collagen (alpha1). In addition, TGF-β; BMPs 2 and 4; Smads 3, 4, 6, and 7; and TIMPs-1 and -2 were increased. In contrast, MMP-9 was strongly down-regulated. Treatment of human bone marrow-derived mesenchymal stem cells with CDDO-Im and CDDO-EA (100 nM) induced expression of SOX9, collagen IIα1, and aggrecan, as well as BMP-2 and phospho-Smad5, confirming that the above triterpenoids induce chondrogenic differentiation. This is the first report of the use of these drugs for induction of chondrogenesis.

KW - Calvarial organ cultures

KW - Chondrogenesis

KW - Stem cells

KW - Synthetic oleanane triterpenoids

KW - Triterpenoids

UR - http://www.scopus.com/inward/record.url?scp=84862807141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862807141&partnerID=8YFLogxK

U2 - 10.1016/j.joca.2012.01.018

DO - 10.1016/j.joca.2012.01.018

M3 - Article

C2 - 22343171

AN - SCOPUS:84862807141

VL - 20

SP - 446

EP - 450

JO - Osteoarthritis and Cartilage

JF - Osteoarthritis and Cartilage

SN - 1063-4584

IS - 5

ER -